Captrust Financial Advisors Takeda Pharmaceutical CO LTD Transaction History

Captrust Financial Advisors

  • $38.8 Billion
  • Q1 2025

A detailed history of Captrust Financial Advisors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Captrust Financial Advisors holds 36,251 shares of TAK stock, worth $519,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,251
Previous 17,434 107.93%
Holding current value
$519,114
Previous $230,000 134.35%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$12.89 - $15.19 $242,551 - $285,830
18,817 Added 107.93%
36,251 $539,000
Q4 2024

Feb 14, 2025
SELL
$13.01 - $14.43 $87,193 - $96,709
-6,702 Reduced 27.77%
17,434 $230,000
Q3 2024

Nov 14, 2024
SELL
$13.0 - $15.08 $25,558 - $29,647
-1,966 Reduced 7.53%
24,136 $342,000
Q2 2024

Aug 14, 2024
SELL
$12.6 - $13.67 $151,200 - $164,040
-12,000 Reduced 31.49%
26,102 $337,000
Q1 2024

May 15, 2024
SELL
$13.89 - $15.04 $253,145 - $274,104
-18,225 Reduced 32.36%
38,102 $529,000
Q4 2023

Feb 14, 2024
SELL
$13.36 - $15.43 $41,228 - $47,616
-3,086 Reduced 5.19%
56,327 $803,000
Q3 2023

Nov 14, 2023
BUY
$15.03 - $16.32 $403,540 - $438,175
26,849 Added 82.45%
59,413 $919,000
Q2 2023

Aug 14, 2023
BUY
$15.57 - $17.11 $17,734 - $19,488
1,139 Added 3.62%
32,564 $511,000
Q1 2023

May 15, 2023
SELL
$15.28 - $16.48 $78,019 - $84,146
-5,106 Reduced 13.98%
31,425 $517,000
Q4 2022

Feb 15, 2023
BUY
$12.42 - $15.62 $255,516 - $321,350
20,573 Added 128.92%
36,531 $570,000
Q3 2022

Nov 16, 2022
BUY
$12.8 - $28.65 $45,478 - $101,793
3,553 Added 28.64%
15,958 $207,000
Q2 2022

Aug 23, 2022
SELL
$13.12 - $15.03 $23,222 - $26,603
-1,770 Reduced 12.49%
12,405 $174,000
Q2 2022

Aug 16, 2022
BUY
$13.12 - $15.03 $75,321 - $86,287
5,741 Added 68.07%
14,175 $199,000
Q1 2022

May 16, 2022
SELL
$13.54 - $15.35 $97,041 - $110,013
-7,167 Reduced 45.94%
8,434 $121,000
Q4 2021

Feb 14, 2022
BUY
$13.17 - $16.4 $103,792 - $129,248
7,881 Added 102.09%
15,601 $213,000
Q3 2021

Nov 16, 2021
SELL
$16.3 - $17.26 $17,669 - $18,709
-1,084 Reduced 12.31%
7,720 $126,000
Q2 2021

Aug 16, 2021
BUY
$16.55 - $18.64 $11,535 - $12,992
697 Added 8.6%
8,804 $148,000
Q1 2021

May 17, 2021
BUY
$16.71 - $19.9 $33,169 - $39,501
1,985 Added 32.42%
8,107 $148,000
Q4 2020

Feb 16, 2021
BUY
$15.39 - $18.97 $29,518 - $36,384
1,918 Added 45.62%
6,122 $111,000
Q3 2020

Nov 17, 2020
BUY
$17.1 - $19.19 $19,699 - $22,106
1,152 Added 37.75%
4,204 $74,000
Q2 2020

Aug 14, 2020
BUY
$14.59 - $19.5 $44,528 - $59,514
3,052 New
3,052 $54,000

Others Institutions Holding TAK

# of Institutions
374
Shares Held
67.4M
Call Options Held
1.72M
Put Options Held
186K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email